BENGALURU (Reuters) – Dr.Reddy’s Laboratories and Global Response Aid FZCO said they terminated their clinical trial in Kuwait of Fujifilm Holdings’ COVID-19 treatment Avigan in patients with moderate to severe symptoms.
A late-stage North American trial of Avigan in patients with mild to moderate COVID-19 will continue, the Indian drugmaker said https://bit.ly/3onNbij on Wednesday in a regulatory filing.
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Amy Caren Daniel)
